Table 1. Existing frameworks for classifying endemicity and burden using pre-defined levels, indicators, and cut-offs.
WHO-AFRO Leprosy burden scale | Brazilian method | |||||||
---|---|---|---|---|---|---|---|---|
Indicators | High | Medium | Low | Hyper-endemic | Very High | High | Medium | Low |
NCDR per 100,000 population | >20 | 10–20 | <10 | >40.00 | 20.00–39.99 | 10.00–19.99 | 2.00–9.99 | <2.00 |
NCDR in children 100,000 population | >20 | 10–20 | <10 | >10.00 | 5.00–9.99 | 2.50–4.99 | 0.50–2.49 | <0.50 |
Prevalence rate per 10,000 | >2 | 1–2 | <1 | 20.0 | 10.0–19.99 | 5.0–9.9 | 1.0–4.9 | <1.0 |
Proportion G2D among new cases per 100,000 population | >20 | 10–20 | <10 | NS | NS | ≥10 | 5–9.9 | <5 |
Proportion MB among new cases | <50 | 50–75 | 76–100 | Indicator not included | ||||
Proportion of females among new | <40 | >60 | 40–60 | Indicator not included | ||||
Proportion of PB / MB cases cured in the year with degree of incapacity II* | Indicator not included | - | - | ≥10 | 5–9.9 | <5 | ||
Proportion of G2D cases cured at time of discharge | Indicator not included | - | - | ≥10 | 5–9.9 | <5 | ||
Detection (new cases) in regions | >100 | 21–100 | 0–20 | Indicator not included | ||||
Detection (new cases) in health district | >20 | 11–20 | 0–10 | Indicator not included | ||||
Prevalence/ detection (p/d) | >2 | 1–2 | <1 | Indicator not included | ||||
G2D rate per 100,000 population | >1 | 0.5–1 | <0.5 | Indicator not included |
NCDR = new case detection rate; G2D = grade-2 disability; MB = multibacillary leprosy; PB = paucibacillary leprosy